Delivery Order SPE2DB24D1007-SPE2DB25FBYXP

Award Date 10/10/24
Potential Completion Date 10/11/24
Potential Value $4.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,044.07, is for the supply of GARDASIL 9 SYRINGE 0.5ML to support federal healthcare programs. The order has an ultimate completion date of November 6, 2023. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract, with a ceiling value of $4,850.34, is for the delivery of GARDASIL 9 SYRINGE 0.5ML, a pharmaceutical product, to support military treatment programs and facilities. The contract has a performance period through March 27, 2024 and does not have a set-aside designation. AmerisourceBergen...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $1,616.78 firm-fixed-price contract is for the supply of GARDASIL 9 SYRINGE 0.5ML pharmaceutical products. The award, which has no set-aside designation, has an ultimate completion date of September 9, 2024. AmerisourceBergen is a major supplier of pharmaceutical and medical products to various federal agencies and healthcare programs, including the military....
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, the prime contractor, for the supply of GARDASIL 9 0.5ML syringes. The contract has a ceiling value of $4,706.21 and a period of performance through March 12, 2024. AmerisourceBergen Drug Corp is a subsidiary of AmerisourceBergen Corporation, a global pharmaceutical sourcing and distribution company. This delivery order is issued under an...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of GARDASIL 9 syringes (0.5 ML). The contract, valued at $37,480.99, has a completion date of July 25, 2024. AmerisourceBergen is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems. This contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of GARDASIL 9 SYRINGE 0.5ML. The award is not set aside for any specific business type. The total ceiling value of the delivery order is $7,678.96, with an ultimate completion date of August 12, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of GARDASIL 9 SYRINGE 0.5ML, a vaccine product, and has a ceiling value of $26,152.42. The contract is a Firm Fixed Price type and runs through March 31, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the leading global pharmaceutical distributor Amerisourcebergen Corporation. The $4,908.73 contract is for the supply of GARDASIL 9 SYRINGE 0.5ML and has a performance period through March 18, 2024. This award is part of Amerisourcebergen Drug Corp's prime contractor role on an indefinite delivery contract (IDC) with DLA, valued up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of GARDASIL 9 syringes. The $30,921.57 firm-fixed-price contract has a period of performance through September 26, 2024. As a major pharmaceutical distributor, AmerisourceBergen provides a wide range of essential medical supplies and prescription drugs to federal agencies, including the military. This award is issued under AmerisourceBergen's $999,999,999 indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for the vaccine GARDASIL 9 SYRINGE 0.5ML, with a ceiling value of $4,705.50 and a completion date of November 6, 2024. The contract is a Firm Fixed Price delivery order, with no set-aside requirement. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB24D1007
    Indefinite Delivery Contract
  • SPE2DB24D1007-SPE2DB25FBYXP
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the supply of GARDASIL 9 SYRINGE 0.5ML. The contract has a ceiling value of $4,325.56 and a completion date of October 11, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this firm fixed-price delivery order as part of a larger Indefinite Delivery Contract with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, to provide a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. This contract does not have a set-aside designation.

Generated 1/9/25, 9:08 AM